Anti-Trump Marchers ‘Mostly White’ Women Who Need
Anti-Trump Marchers ‘Mostly White’ Women Who Need ‘Therapy’ After Clinton Loss
The tens of thousands of women marching in the anti-Trump Women’s March on Washington demonstration in Washington, D.C., Saturday are “mostly white” and experiencing “therapy” for their anxiety over Hillary Clinton’s election loss to Donald Trump in November, the Washington Post reports.
According to the Post:
Marchers — mostly women and mostly white — said they came to take the most public possible stand against Trump, a candidate and now president whom they said routinely insults women and the issues they care about. But the gathering also provided therapy for many, the balm of immersing themselves in a like-minded sea of citizens who had shared their anxiety and disappointment after Democrat Hillary Clinton’s historic bid for the presidency ended in defeat.
The report notes some of the women are “sometimes sleeping on the couches of people they had never met before” due to the vast crowd participating in the march.
“Organizers, who originally sought a permit for a gathering of 200,000, said Saturday they now expect as many as a half million participants – potentially dwarfing Friday’s inaugural crowd,” the report says:
The march’s central focus appears to be to protect abortion chain Planned Parenthood from taxpayer defunding, one of the stated goals of the Trump administration. Though cast as a “women’s rights” march, pro-life women who attempted to register for the march were refused.
“If you want to come to the march you are coming with the understanding that you respect a woman’s right to choose,” Linda Sarsour, a Palestinian-American Muslim racial justice and civil rights activist, and a chairwoman of the event, told the New York Times.
Feminist Gloria Steinem and Planned Parenthood have partnered for the event, providing it with its decidedly anti-Trump tone.
On her website, Steinem says to her fans:
We have all the powers we had [before Trump was elected] of lobbying and pressuring and making clear that the political consequences are great. We may look up and feel powerless and think there’s nothing we can do, but it’s not true. There are things we can do at each level. And there’s always civil disobedience. Trump is not my president.
Steinem also recently said she would refuse to pay the full amount of her federal income tax if Planned Parenthood’s taxpayer funds were eliminated.
Planned Parenthood President Cecile Richards said about the march:
We will send a strong message to the incoming administration that millions of people across this country are prepared to fight attacks on reproductive health care, abortion services, and access to Planned Parenthood, as they intersect with the rights of young people, people of color, immigrants, and people of all faiths, backgrounds, and incomes.
According to the march’s website, its mission is to “send a bold message to our new government on their first day in office, and to the world that women’s rights are human rights.”
Democrat Sens. Patty Murray (WA) and Elizabeth Warren (MA) are supporting Planned Parenthood:
Despite its message of unity among all the left’s political identity groups, the Times previously reported the “Women’s March” has been anything but unified from its inception:
On the march group’s Facebook page, it is easy to see how complicated the idea of the “women’s vote,” an already mythological concept, has become, and how difficult it might be for organizers to fulfill their aim of gathering women who remain fiercely divided on reproductive rights, gun control, same-sex marriage and immigration, among other issues.
Not everyone on the page believes, for instance, that Hillary Clinton would have made a good president, or that Stephen K. Bannon, a chief strategist under Mr. Trump, holds divisive views about minorities. Debates over both have sprung up in recent days. Bob Bland, one of the march’s organizers, said in an email that organizers in Maryland had to change a Facebook page from public to private to protect the safety of women who want to attend.
Writing at the Week, abortion rights supporter Shikha Dalmia asserts the demonstration has already failed in its mission.
“Demonstrations serve a useful function in a democracy — but only when they have clarity of purpose,” she writes, adding that the march is “shaping up to be a feel-good exercise in search of a cause.”
Dalmia writes some of the “absurdity” related to the event stems from “the fact that they are billing this event as the voice of women when 42 percent of women (and 62 percent of non-college educated white women) actually voted for Trump.”
She also observes “the almost-comical progressive hysteria over the event’s name.” The initial plan by the “three white women” organizers, she says, was to call the event the “Million Women March,” but the women were criticized for “cultural appropriation” for “allegedly poaching the heritage of the 1997 Million Woman March for black women.”
“Feminists are confusing the issue by making Trump’s threat about themselves,” Dalmia concludes. “If they really wanted to help, they would have kept their powder dry for now, rather than embark on this confused and pointless march.”
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...
Continue Reading
Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...
Continue Reading
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue Reading
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
Top 5 Most Recently Viewed Articles
Standex Reports Fiscal First Quarter Results Standex International Corporation (NYSE: SXI) has recently released its financial results for the first quarter of fiscal year 2026, marking a substantial increase in performance compared to the previous year. With sales soaring by 27.6% year-over-year to reach $217.4 million, the company has shown incredible resilience and...
Continue Reading
Nasdaq 100 Approaching Historic Peaks Recently, the Nasdaq 100 futures have shown notable resilience, climbing more than 3% as they responded positively to key support levels established the prior week. Currently, the index is flirting with new all-time highs, merely 300 points away from breaking past significant barriers that could reshape market expectations. Key...
Continue Reading
Investigation Announced for Jayud Global Logistics Investors Attention shareholders of Jayud Global Logistics Limited (NASDAQ: JYD). Recent developments surrounding this company have led to significant concerns about the accuracy of their public statements. An investigation is currently being initiated for investors who may have incurred losses. The Nature of the...
Continue Reading
Adona Medical's First-in-Human Study on Innovative Shunt Adona Medical, a company well-known for its cutting-edge solutions for heart failure management, recently made significant strides with its new interatrial shunt technology. The company is spearheading its first-in-human study to assess the capabilities of this innovative device, which aims to enhance the...
Continue Reading
Hyundai Motor's Q3 Profit Decline: Key Insights Hyundai Motor Co, a leading name in the automotive sector, has announced a noteworthy decline in its third-quarter operating profit. This shift marks a 7% decrease compared to the previous year's performance, signaling the impact of a global slowdown in car demand on the company. Understanding the Financial Figures For the...
Continue Reading